Quanterix Corporation (QTRX)
QTRXNASDAQ-GMBiotechnology: Laboratory Analytical Instruments
$2.93
+0.0700 (+2.45%) today
Closed, Nov 13, 4:00 PM ET
- Market cap
- $139.11m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $2.15 to $8.77
- Average volume
- –
- Previous close
- $2.86
Analysts
2 coveringHold0 buy, 2 hold, 0 sell
Targets a year out average $3.50, +19.5% from here
Earnings
Next report
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $43.85m | $36.41m | $32.91m | $34.97m |
| Gross profit | $24.22m | $15.57m | $12.68m | $13.50m |
| Operating income | -$24.75m | -$41.36m | -$49.43m | -$22.50m |
| Net income | -$23.12m | -$17.54m | -$48.93m | -$21.59m |
Last four quarters: revenue $148.15m, margin -75.0%, free cash flow -$56.03m
News
8 latest- Quanterix Corporation Reports $35.0 million in Q3 2026 revenue and Narrows Full-Year Revenue Outlook to $142-146 millionFintel · 6 days ago
- Quanterix Corp (QTRX) Q3 2026 Earnings Call TranscriptThe Motley Fool · 6 days ago
- What Quanterix (QTRX) Said on Its Q3 Earnings CallMarketBeat · 6 days ago
- Quanterix Corp Q3 Loss Decreases RTTNews · 6 days ago
- Tuesday Sector Laggards: Medical Instruments & Supplies, Advertising Stocks BNK Invest · Oct 6, 2026
- Quanterix Names Yuri Fesko Chief Medical Officer RTTNews · Sep 14, 2026
- Quanterix (QTRX) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 17, 2026
- Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood TestMarketBeat · Aug 16, 2026
The company
Quanterix is a global leader in precision biomarker science, making biology measurable to deliver earlier insights and support breakthroughs in disease research, diagnostics, and drug development. Its SIMOA technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. Through the acquisition of Akoya Biosciences, Quanterix Spatial solutions deliver high-plex, quantitative protein analysis in tissue at single-cell resolution. Combined with Accelerator Laboratory services, Quanterix gives researchers the tools and expertise to translate discovery into precision diagnostics.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- quanterix.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.